← Back to Clinical Trials
Recruiting NCT07212660

NCT07212660 A Clinical Trial to Compare the Safety and Performance of Two Different Curing Modes in the Direct Filling Therapy in Deciduous Teeth

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07212660
Status Recruiting
Phase
Sponsor Ivoclar Vivadent AG
Condition Dental Caries
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2025-12-18
Primary Completion 2026-11

Eligibility & Interventions

Sex All sexes
Min Age 4 Years
Max Age 9 Years
Study Type INTERVENTIONAL
Interventions
Fast curing modeConventional curing mode

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2025-12-18 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The overall aim of this clinical investigation is to assess the clinical performance and safety of composite restorations cured with fast curing mode (5 seconds with 2000 mW/cm²) in primary molars.

Eligibility Criteria

Inclusion Criteria: * Consent of a legal representative (usually parents) * 2 deciduous molars in the need of direct filling therapy class I and/or II in different quadrants (primary or secondary caries, filling loss) * Classification of caries: caries of all sizes in deciduous molars are included unless they can be treated with fissure sealing (ICDAS 3, 4, 5) * Sufficient language skills of legal representative and children * Teeth in the need of indirect pulp capping if necessary (Operator decision) Exclusion Criteria: * Cognitive impairment not age-appropriate * Sensitive tooth (pain at night, irritation-persistent pain, buccal swelling, percussion sensitivity) * Teeth with severely resorbed roots (anormal tooth mobility) * Direct pulp capping * Pulpotomy of an adjacent tooth in the same appointment * Noncompliant child * Allergies to material or anaesthetics used in the study * Sufficient isolation not possible

Frequently Asked Questions

Who can join the NCT07212660 clinical trial?

This trial is open to participants of all sexes, aged 4 Years or older, up to 9 Years, studying Dental Caries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07212660 currently recruiting?

Yes, NCT07212660 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ivoclar Vivadent AG to inquire about joining.

Where is the NCT07212660 trial being conducted?

This trial is being conducted at Herzogenbuchsee, Switzerland, Willisau, Switzerland.

Who is sponsoring the NCT07212660 clinical trial?

NCT07212660 is sponsored by Ivoclar Vivadent AG. The trial plans to enroll 70 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology